Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.

Skinner D, Marro BS, Lane TE.

Viral Immunol. 2018 Aug 15. doi: 10.1089/vim.2018.0073. [Epub ahead of print]

PMID:
30109979
2.

Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.

Mangale V, McIntyre LL, Walsh CM, Loring JF, Lane TE.

Dev Dyn. 2018 Aug 1. doi: 10.1002/dvdy.24658. [Epub ahead of print] Review.

PMID:
30067309
3.

Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment.

Grist JJ, Marro BS, Skinner DD, Syage AR, Worne C, Doty DJ, Fujinami RS, Lane TE.

Eur J Immunol. 2018 Jul;48(7):1199-1210. doi: 10.1002/eji.201747442. Epub 2018 May 16.

4.

Regulated release of cryptococcal polysaccharide drives virulence and suppresses immune infiltration into the central nervous system.

Denham ST, Verma S, Reynolds RC, Worne CL, Daugherty JM, Lane TE, Brown JCS.

Infect Immun. 2017 Dec 4. pii: IAI.00662-17. doi: 10.1128/IAI.00662-17. [Epub ahead of print]

5.

Neural precursor cells derived from induced pluripotent stem cells exhibit reduced susceptibility to infection with a neurotropic coronavirus.

Mangale V, Marro BS, Plaisted WC, Walsh CM, Lane TE.

Virology. 2017 Nov;511:49-55. doi: 10.1016/j.virol.2017.08.003. Epub 2017 Aug 17.

PMID:
28822268
6.

Preface.

Lane TE.

J Neuroimmunol. 2017 Jul 15;308:1. doi: 10.1016/j.jneuroim.2017.05.016. Epub 2017 May 25. No abstract available.

PMID:
28623960
7.

Microbiota promotes systemic T-cell survival through suppression of an apoptotic factor.

Soto R, Petersen C, Novis CL, Kubinak JL, Bell R, Stephens WZ, Lane TE, Fujinami RS, Bosque A, O'Connell RM, Round JL.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):5497-5502. doi: 10.1073/pnas.1619336114. Epub 2017 May 9.

8.

Speaking out about gender imbalance in invited speakers improves diversity.

Klein RS, Voskuhl R, Segal BM, Dittel BN, Lane TE, Bethea JR, Carson MJ, Colton C, Rosi S, Anderson A, Piccio L, Goverman JM, Benveniste EN, Brown MA, Tiwari-Woodruff SK, Harris TH, Cross AH.

Nat Immunol. 2017 Apr 18;18(5):475-478. doi: 10.1038/ni.3707. No abstract available.

9.

MicroRNA 155 and viral-induced neuroinflammation.

Dickey LL, Hanley TM, Huffaker TB, Ramstead AG, O'Connell RM, Lane TE.

J Neuroimmunol. 2017 Jul 15;308:17-24. doi: 10.1016/j.jneuroim.2017.01.016. Epub 2017 Jan 24. Review.

10.

MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.

Dickey LL, Worne CL, Glover JL, Lane TE, O'Connell RM.

J Neuroinflammation. 2016 Sep 7;13(1):240. doi: 10.1186/s12974-016-0699-z.

11.

Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.

Plaisted WC, Zavala A, Hingco E, Tran H, Coleman R, Lane TE, Loring JF, Walsh CM.

PLoS One. 2016 Jun 16;11(6):e0157620. doi: 10.1371/journal.pone.0157620. eCollection 2016.

12.

Neutrophils and viral-induced neurologic disease.

Grist JJ, Marro B, Lane TE.

Clin Immunol. 2018 Apr;189:52-56. doi: 10.1016/j.clim.2016.05.009. Epub 2016 Jun 8.

PMID:
27288312
13.

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis.

Yandamuri SS, Lane TE.

Front Immunol. 2016 May 19;7:189. doi: 10.3389/fimmu.2016.00189. eCollection 2016. Review.

14.

The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.

Marsh SE, Abud EM, Lakatos A, Karimzadeh A, Yeung ST, Davtyan H, Fote GM, Lau L, Weinger JG, Lane TE, Inlay MA, Poon WW, Blurton-Jones M.

Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1316-25. doi: 10.1073/pnas.1525466113. Epub 2016 Feb 16.

15.

Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.

Marro BS, Grist JJ, Lane TE.

J Immunol. 2016 Feb 15;196(4):1855-64. doi: 10.4049/jimmunol.1501802. Epub 2016 Jan 15.

16.

Sphingosine-1-phosphate receptor antagonism enhances proliferation and migration of engrafted neural progenitor cells in a model of viral-induced demyelination.

Blanc CA, Grist JJ, Rosen H, Sears-Kraxberger I, Steward O, Lane TE.

Am J Pathol. 2015 Oct;185(10):2819-32. doi: 10.1016/j.ajpath.2015.06.009.

17.

Design and Validation of a Research-Grade Waterpipe Equipped With Puff Topography Analyzer.

Brinkman MC, Kim H, Gordon SM, Kroeger RR, Reyes IL, Deojay DM, Chitwood C, Lane TE, Clark PI.

Nicotine Tob Res. 2016 May;18(5):785-93. doi: 10.1093/ntr/ntv180. Epub 2015 Sep 16.

18.

Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice.

Herz J, Sabellek P, Lane TE, Gunzer M, Hermann DM, Doeppner TR.

Stroke. 2015 Oct;46(10):2916-25. doi: 10.1161/STROKEAHA.115.010620. Epub 2015 Sep 3.

19.

Two-photon imaging of cellular dynamics in the mouse spinal cord.

Weinger JG, Greenberg ML, Matheu MP, Parker I, Walsh CM, Lane TE, Cahalan MD.

J Vis Exp. 2015 Feb 22;(96). doi: 10.3791/52580.

20.

Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Marro BS, Blanc CA, Loring JF, Cahalan MD, Lane TE.

Expert Rev Neurother. 2014 Oct;14(10):1169-79. doi: 10.1586/14737175.2014.955854. Review.

21.

FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.

Blanc CA, Rosen H, Lane TE.

J Neuroinflammation. 2014 Aug 20;11:138. doi: 10.1186/s12974-014-0138-y.

22.

Axonal pathology and demyelination in viral models of multiple sclerosis.

Libbey JE, Lane TE, Fujinami RS.

Discov Med. 2014 Jul-Aug;18(97):79-89. Review.

23.

ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease.

Hosking MP, Lane TE.

Front Cell Neurosci. 2014 Jun 17;8:165. doi: 10.3389/fncel.2014.00165. eCollection 2014. Review.

24.

Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.

Chen L, Coleman R, Leang R, Tran H, Kopf A, Walsh CM, Sears-Kraxberger I, Steward O, Macklin WB, Loring JF, Lane TE.

Stem Cell Reports. 2014 May 15;2(6):825-37. doi: 10.1016/j.stemcr.2014.04.005. eCollection 2014 Jun 3.

25.

Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Weinger JG, Plaisted WC, Maciejewski SM, Lanier LL, Walsh CM, Lane TE.

Stem Cells. 2014 Oct;32(10):2690-701. doi: 10.1002/stem.1760.

26.

Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.

Greenberg ML, Weinger JG, Matheu MP, Carbajal KS, Parker I, Macklin WB, Lane TE, Cahalan MD.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2349-55. doi: 10.1073/pnas.1406658111. Epub 2014 May 19.

27.

Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells.

Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ.

Glia. 2014 Sep;62(9):1418-34. doi: 10.1002/glia.22689. Epub 2014 May 7.

28.

Spinal cord injury, immunodepression, and antigenic challenge.

Held KS, Lane TE.

Semin Immunol. 2014 Oct;26(5):415-20. doi: 10.1016/j.smim.2014.03.003. Epub 2014 Apr 18. Review.

29.

Intraspinal transplantation of mouse and human neural precursor cells.

Weinger JG, Chen L, Coleman R, Leang R, Plaisted WC, Loring JF, Lane TE.

Curr Protoc Stem Cell Biol. 2013 Sep 20;26:Unit 2D.16.. doi: 10.1002/9780470151808.sc02d16s26.

30.

T cell mediated suppression of neurotropic coronavirus replication in neural precursor cells.

Plaisted WC, Weinger JG, Walsh CM, Lane TE.

Virology. 2014 Jan 20;449:235-43. doi: 10.1016/j.virol.2013.11.025. Epub 2013 Dec 12.

31.

WSX-1 signalling inhibits CD4⁺ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways.

Villegas-Mendez A, Gwyer Findlay E, de Souza JB, Grady LM, Saris CJ, Lane TE, Riley EM, Couper KN.

PLoS One. 2013 Nov 7;8(11):e78486. doi: 10.1371/journal.pone.0078486. eCollection 2013.

32.

The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.

Weinger JG, Marro BS, Hosking MP, Lane TE.

Virology. 2013 Jan 5;435(1):110-7. doi: 10.1016/j.virol.2012.08.049. Review.

33.

Chitinase dependent control of protozoan cyst burden in the brain.

Nance JP, Vannella KM, Worth D, David C, Carter D, Noor S, Hubeau C, Fitz L, Lane TE, Wynn TA, Wilson EH.

PLoS Pathog. 2012;8(11):e1002990. doi: 10.1371/journal.ppat.1002990. Epub 2012 Nov 29.

34.

Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis.

Tirotta E, Duncker P, Oak J, Klaus S, Tsukamoto MR, Gov L, Lane TE.

J Neuroimmunol. 2013 Jan 15;254(1-2):110-6. doi: 10.1016/j.jneuroim.2012.10.005. Epub 2012 Oct 26.

35.

MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination.

Weinger JG, Weist BM, Plaisted WC, Klaus SM, Walsh CM, Lane TE.

Stem Cells. 2012 Nov;30(11):2584-95. doi: 10.1002/stem.1234.

36.

Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections.

Zhao J, Wohlford-Lenane C, Zhao J, Fleming E, Lane TE, McCray PB Jr, Perlman S.

J Virol. 2012 Nov;86(21):11416-24. doi: 10.1128/JVI.01410-12. Epub 2012 Aug 22.

37.

IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling.

Tirotta E, Kirby LA, Hatch MN, Lane TE.

Stem Cell Res. 2012 Nov;9(3):208-17. doi: 10.1016/j.scr.2012.06.005. Epub 2012 Jun 29.

38.

CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis.

Marro BS, Hosking MP, Lane TE.

Future Virol. 2012 Apr;7(4):349-359.

39.

Chronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in mice.

Oropallo MA, Held KS, Goenka R, Ahmad SA, O'Neill PJ, Steward O, Lane TE, Cancro MP.

J Immunol. 2012 Jun 1;188(11):5257-66. doi: 10.4049/jimmunol.1101934. Epub 2012 Apr 20.

40.

Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.

Whitman LM, Blanc CA, Schaumburg CS, Rowitch DH, Lane TE.

Exp Neurol. 2012 May;235(1):380-7. doi: 10.1016/j.expneurol.2012.03.003. Epub 2012 Mar 17.

41.

Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut.

Liu JZ, Jellbauer S, Poe AJ, Ton V, Pesciaroli M, Kehl-Fie TE, Restrepo NA, Hosking MP, Edwards RA, Battistoni A, Pasquali P, Lane TE, Chazin WJ, Vogl T, Roth J, Skaar EP, Raffatellu M.

Cell Host Microbe. 2012 Mar 15;11(3):227-39. doi: 10.1016/j.chom.2012.01.017.

42.

Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity.

Lu JV, Weist BM, van Raam BJ, Marro BS, Nguyen LV, Srinivas P, Bell BD, Luhrs KA, Lane TE, Salvesen GS, Walsh CM.

Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15312-7. doi: 10.1073/pnas.1102779108. Epub 2011 Aug 29.

43.

CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination.

Carbajal KS, Miranda JL, Tsukamoto MR, Lane TE.

Glia. 2011 Dec;59(12):1813-21. doi: 10.1002/glia.21225. Epub 2011 Aug 9.

44.

Surgical transplantation of mouse neural stem cells into the spinal cords of mice infected with neurotropic mouse hepatitis virus.

Carbajal KS, Weinger JG, Whitman LM, Schaumburg CS, Lane TE.

J Vis Exp. 2011 Jul 10;(53):e2834. doi: 10.3791/2834.

45.

Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.

Sullivan NL, Eickhoff CS, Zhang X, Giddings OK, Lane TE, Hoft DF.

J Immunol. 2011 Aug 1;187(3):1358-68. doi: 10.4049/jimmunol.1100033. Epub 2011 Jun 29.

46.

CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-γ/CXCL10-mediated apoptosis.

Tirotta E, Ransohoff RM, Lane TE.

Glia. 2011 Oct;59(10):1518-28. doi: 10.1002/glia.21195. Epub 2011 Jun 8.

47.

Inflammation induced by infection potentiates tau pathological features in transgenic mice.

Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, Laferla FM.

Am J Pathol. 2011 Jun;178(6):2811-22. doi: 10.1016/j.ajpath.2011.02.012. Epub 2011 Apr 30.

48.

G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands.

Köhler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Männ L, Ransohoff RM, Hauser AE, Winter O, Schraven B, Geiger H, Hogg N, Gunzer M.

Blood. 2011 Apr 21;117(16):4349-57. doi: 10.1182/blood-2010-09-308387. Epub 2011 Jan 11.

49.

Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection.

Held KS, Steward O, Blanc C, Lane TE.

Exp Neurol. 2010 Nov;226(1):242-53. doi: 10.1016/j.expneurol.2010.08.036. Epub 2010 Sep 9.

50.

The role of chemokines during viral infection of the CNS.

Hosking MP, Lane TE.

PLoS Pathog. 2010 Jul 29;6(7):e1000937. doi: 10.1371/journal.ppat.1000937. Review. No abstract available.

Supplemental Content

Support Center